Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy (Q36898404)
Jump to navigation
Jump to search
scientific article published on 28 April 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy |
scientific article published on 28 April 2016 |
Statements
Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy (English)
S Bowyer
P Prithviraj
J Larkin
V Atkinson
M Millward
M Khou
S Diem
S Ramanujam
E Liniker
A Guminski
P Parente
S Parakh
M S Carlino